Rita Jain - 30 Sep 2025 Form 4 Insider Report for Avalo Therapeutics, Inc. (AVTX)

Role
Director
Signature
/s/ Donald R. Reynolds, by Power of Attorney
Issuer symbol
AVTX
Transactions as of
30 Sep 2025
Transactions value $
$0
Form type
4
Filing time
02 Oct 2025, 16:11:27 UTC
Previous filing
18 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Jain Rita Director C/O AVALO THERAPEUTICS, INC., 1500 LIBERTY RIDGE DRIVE, SUITE 321, WAYNE /s/ Donald R. Reynolds, by Power of Attorney 02 Oct 2025 0001707797

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AVTX Stock Option (Right to Buy) Award $0 +1,572 $0 1,572 30 Sep 2025 Common Stock 1,572 $12.71 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options were granted on September 30, 2025, and are 100% vested.